Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality

CMAJ

Volumn 189, Issue 10, 2017, Pages E384-E390

  Singh Manoux, Archana ^a   Shipley, Martin J ^b   Bell, Joshua A ^b   Canonico, Marianne ^a   Elbaz, Alexis ^a   Kivimaki, Mika ^b  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; OROSOMUCOID; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; CAUSE OF DEATH; CHRONIC DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; PROTEIN BLOOD LEVEL; SOCIAL STATUS; BLOOD; COHORT ANALYSIS; INFLAMMATION; MIDDLE AGED; MORTALITY; NEOPLASM; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; UNITED KINGDOM;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPLASMS; OROSOMUCOID; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; UNITED KINGDOM;

EID: 85015203016     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.160313     Document Type: Article

References (26)

1. Rawat R, Humphrey JH, Mutasa K, et al. Short communication: Predicting adverse HIV-related outcomes in a resource-limited setting: Use of the inflammation marker alpha(1)-acid glycoprotein. AIDS Res Hum Retroviruses 2010;26:1171-4.
2. Wells G, Becker JC, Teng J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 2009;68:954-60.
3. Volpato S, Guralnik JM, Ferrucci L, et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: The women's health and aging study. Circulation 2001;103: 947-53.
4. Lowe G, Woodward M, Hillis G, et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: The ADVANCE study. Diabetes 2014;63:1115-23.
5. Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000; 343: 1139-47.
6. Kaptoge S, Di Angelantonio E, Lowe G, et al.; Emerging Risk Factors Collaborators. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2010; 375:132-40.
7. Zacho J, Tybjaerg-Hansen A, Jensen JS, et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897-908.
8. Sarwar N, Butterworth AS, Freitag DF, et al.; IL6R Genetics Consortium Emerging Risk Factors Collaboration. Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-analysis of 82 studies. Lancet 2012; 379:1205-13.
9. Fischer K, Kettunen J, Wurtz P, et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: An observational study of 17 345 persons. PLoS Med 2014;11:e1001606.
10. Marmot MG, Smith GD, Stansfeld S, et al. Health inequalities among British civil servants: The Whitehall II study. Lancet 1991; 337:1387-93.
11. Wurtz P, Havulinna AS, Soininen P, et al. Metabolite profiling and cardiovascular event risk: A prospective study of 3 population-based cohorts. Circulation 2015;131:774-85.
12. Council MR. Definition and classification of chronic bronchitis for epidemiological purposes. Lancet 1965;i:775-9.
13. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
14. Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.
15. Luo Z, Lei H, Sun Y, et al. Orosomucoid, an acute response protein with multiple modulating activities. J Physiol Biochem 2015;71:329-40.
16. Interleukin-6 Receptor Mendelian Randomisation Analysis Consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: A mendelian randomisation analysis. Lancet 2012;379:1214-24.
17. Wensley F, Gao P, Burgess S, et al.; C Reactive Protein Coronary Heart Disease Genetics Consortium. Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data. BMJ 2011;342:d548.
18. Rattazzi M, Puato M, Faggin E, et al. C-reactive protein and interleukin-6 in vascular disease: Culprits or passive bystanders?. J Hypertens 2003;21:1787-803.
19. Jurk D, Wilson C, Passos JF, et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat Commun 2014;2:4172.
20. Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007;128: 92-105.
21. Chung HY, Cesari M, Anton S, et al. Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res Rev 2009;8:18-30.
22. Tosto G, Reitz C. Genome-wide association studies in Alzheimer's disease: A review. Curr Neurol Neurosci Rep 2013;13:381.
23. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013;45:1452-8.
24. Carriere I, Dupuy AM, Lacroux A, et al. Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people. J Am Geriatr Soc 2008;56:840-6.
25. Henry OF, Blacher J, Verdavaine J, et al. Alpha 1-acid glycoprotein is an independent predictor of in-hospital death in the elderly. Age Ageing 2003;32:37-42.
26. Batty GD, Shipley M, Tabak A, et al. Generalizability of occupational cohort study findings. Epidemiology 2014;25:932-3.